1
|
Yu E, Koffer PP, DiPetrillo TA and
Kinsella TJ: Incidence, treatment, and survival patterns for sacral
chordoma in the United States, 1974–2011. Front Oncol. 6:2032016.
View Article : Google Scholar : PubMed/NCBI
|
2
|
Chugh R, Tawbi H, Lucas DR, Biermann JS,
Schuetze SM and Baker LH: Chordoma: The nonsarcoma primary bone
tumor. Oncologist. 12:1344–1350. 2007. View Article : Google Scholar : PubMed/NCBI
|
3
|
Imai R, Kamada T, Sugahara S, Tsuji H and
Tsujii H: Carbon ion radiotherapy for sacral chordoma. Br J Radiol.
84:S48–S54. 2011. View Article : Google Scholar : PubMed/NCBI
|
4
|
Lorenzo C, Andrea P, Barbara V, Denis P,
Rosaria FM, Piero F, Viviana V, Alberto I, Mario C, Brugnatelli S,
et al: Surgical spacer placement prior carbon ion radiotherapy
(CIRT): An effective feasible strategy to improve the treatment for
sacral chordoma. World J Surg Oncol. 14:2112016. View Article : Google Scholar : PubMed/NCBI
|
5
|
Kamada T, Tsujii H, Blakely EA, Debus J,
De Neve W, Durante M, Jäkel O, Mayer R, Orecchia R, Pötter R, et
al: Carbon ion radiotherapy in Japan: An assessment of 20 years of
clinical experience. Lancet Oncol. 16:e93–e100. 2015. View Article : Google Scholar : PubMed/NCBI
|
6
|
Varga PP, Szövérfi Z, Fisher CG, Boriani
S, Gokaslan ZL, Dekutoski MB, Chou D, Quraishi NA, Reynolds JJ,
Luzzati A, et al: Surgical treatment of sacral chordoma: Prognostic
variables for local recurrence and overall survival. Eur Spine J.
24:1092–1101. 2015. View Article : Google Scholar : PubMed/NCBI
|
7
|
Radaelli S, Stacchiotti S, Ruggieri P,
Donati D, Casali PG, Palmerini E, Collini P, Gambarotti M, Porcu L,
Boriani S, et al: Sacral chordoma: Long-term outcome of a large
series of patients surgically treated at two reference centers.
Spine. 41:1049–1057. 2016. View Article : Google Scholar : PubMed/NCBI
|
8
|
Yang Y, Niu X, Li Y, Liu W and Xu H:
Recurrence and survival factors analysis of 171 cases of sacral
chordoma in a single institute. Eur Spine J. 26:1910–1916. 2017.
View Article : Google Scholar : PubMed/NCBI
|
9
|
Stacchiotti S and Sommer J; Chordoma
Global Consensus Group, : Building a global consensus approach to
chordoma: A position paper from the medical and patient community.
Lancet Oncol. 16:e71–e83. 2015. View Article : Google Scholar : PubMed/NCBI
|
10
|
Asavamongkolkul A and Waikakul S: Wide
resection of sacral chordoma via a posterior approach. Int Orthop.
36:607–612. 2012. View Article : Google Scholar : PubMed/NCBI
|
11
|
Demizu Y, Jin D, Sulaiman NS, Nagano F,
Terashima K, Tokumaru S, Akagi T, Fujii O, Daimon T, Sasaki R, et
al: Particle therapy using protons or carbon ions for unresectable
or incompletely resected bone and soft tissue sarcomas of the
pelvis. Int J Radiat Oncol Biol Phys. 98:367–374. 2017. View Article : Google Scholar : PubMed/NCBI
|
12
|
Imai R, Kamada T, Araki N, Abe S, Iwamoto
Y, Ozaki T, Kanehira C, Kaya M, Takahashi K, Chuman H, et al
Working Group for Bone and Soft Tissue Sarcomas, : Carbon ion
radiation therapy for unresectable sacral chordoma: An analysis of
188 cases. Int J Radiat Oncol Biol Phys. 95:322–327. 2016.
View Article : Google Scholar : PubMed/NCBI
|
13
|
Wallner K, Sutlief S, Bergsagel C and
Merrick GS: Severe rectal complications after prostate
brachytherapy. Radiother Oncol. 114:272–275. 2015. View Article : Google Scholar : PubMed/NCBI
|
14
|
Huvos AG, Woodard HQ, Cahan WG,
Higinbotham NL, Stewart FW, Butler A and Bretsky SS: Postradiation
osteogenic sarcoma of bone and soft tissues. A clinicopathologic
study of 66 patients. Cancer. 55:1244–1255. 1985. View Article : Google Scholar : PubMed/NCBI
|
15
|
Mavrogenis AF, Pala E, Guerra G and
Ruggieri P: Post-radiation sarcomas. Clinical outcome of 52
Patients. J Surg Oncol. 105:570–576. 2012. View Article : Google Scholar : PubMed/NCBI
|